These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

149 related articles for article (PubMed ID: 9152224)

  • 1. Evaluation of the gene encoding the tissue inhibitor of metalloproteinases-3 in various maculopathies.
    Felbor U; Doepner D; Schneider U; Zrenner E; Weber BH
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1054-9. PubMed ID: 9152224
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Exclusion of TIMP3 as a candidate locus in age-related macular degeneration.
    De La Paz MA; Pericak-Vance MA; Lennon F; Haines JL; Seddon JM
    Invest Ophthalmol Vis Sci; 1997 May; 38(6):1060-5. PubMed ID: 9152225
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mutations in the tissue inhibitor of metalloproteinases-3 (TIMP3) in patients with Sorsby's fundus dystrophy.
    Weber BH; Vogt G; Pruett RC; Stöhr H; Felbor U
    Nat Genet; 1994 Dec; 8(4):352-6. PubMed ID: 7894485
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TIMP3 mutation in Sorsby's fundus dystrophy: molecular insights.
    Li Z; Clarke MP; Barker MD; McKie N
    Expert Rev Mol Med; 2005 Oct; 7(24):1-15. PubMed ID: 16259644
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A substitution of G to C in the cone cGMP-phosphodiesterase gamma subunit gene found in a distinctive form of cone dystrophy.
    Piri N; Gao YQ; Danciger M; Mendoza E; Fishman GA; Farber DB
    Ophthalmology; 2005 Jan; 112(1):159-66. PubMed ID: 15629837
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A second independent Tyr168Cys mutation in the tissue inhibitor of metalloproteinases-3 (TIMP3) in Sorsby's fundus dystrophy.
    Felbor U; Stöhr H; Amann T; Schönherr U; Apfelstedt-Sylla E; Weber BH
    J Med Genet; 1996 Mar; 33(3):233-6. PubMed ID: 8728699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutations in the VMD2 gene are associated with juvenile-onset vitelliform macular dystrophy (Best disease) and adult vitelliform macular dystrophy but not age-related macular degeneration.
    Krämer F; White K; Pauleikhoff D; Gehrig A; Passmore L; Rivera A; Rudolph G; Kellner U; Andrassi M; Lorenz B; Rohrschneider K; Blankenagel A; Jurklies B; Schilling H; Schütt F; Holz FG; Weber BH
    Eur J Hum Genet; 2000 Apr; 8(4):286-92. PubMed ID: 10854112
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A mouse model for Sorsby fundus dystrophy.
    Weber BH; Lin B; White K; Kohler K; Soboleva G; Herterich S; Seeliger MW; Jaissle GB; Grimm C; Reme C; Wenzel A; Asan E; Schrewe H
    Invest Ophthalmol Vis Sci; 2002 Aug; 43(8):2732-40. PubMed ID: 12147610
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A novel diagnostic test detects a low frequency of the hemicentin Gln5345Arg variant among Northern Irish age related macular degeneration patients.
    McKay GJ; Clarke S; Hughes A; McConnell V; Schultz DW; Klein ML; Silvestri G; Simpson DA
    Mol Vis; 2004 Sep; 10():682-7. PubMed ID: 15467524
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Alport syndrome. Molecular genetic aspects.
    Hertz JM
    Dan Med Bull; 2009 Aug; 56(3):105-52. PubMed ID: 19728970
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sorsby's fundus dystrophy. A South African family with a point mutation on the tissue inhibitor of metalloproteinases-3 gene on chromosome 22.
    Peters AL; Greenberg J
    Retina; 1995; 15(6):480-5. PubMed ID: 8747441
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mutated alleles of the rod and cone Na-Ca+K-exchanger genes in patients with retinal diseases.
    Sharon D; Yamamoto H; McGee TL; Rabe V; Szerencsei RT; Winkfein RJ; Prinsen CF; Barnes CS; Andreasson S; Fishman GA; Schnetkamp PP; Berson EL; Dryja TP
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1971-9. PubMed ID: 12037007
    [TBL] [Abstract][Full Text] [Related]  

  • 13. VMD2 mutations in vitelliform macular dystrophy (Best disease) and other maculopathies.
    White K; Marquardt A; Weber BH
    Hum Mutat; 2000; 15(4):301-8. PubMed ID: 10737974
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Night blindness in Sorsby's fundus dystrophy reversed by vitamin A.
    Jacobson SG; Cideciyan AV; Regunath G; Rodriguez FJ; Vandenburgh K; Sheffield VC; Stone EM
    Nat Genet; 1995 Sep; 11(1):27-32. PubMed ID: 7550309
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel His158Arg mutation in TIMP3 causes a late-onset form of Sorsby fundus dystrophy.
    Lin RJ; Blumenkranz MS; Binkley J; Wu K; Vollrath D
    Am J Ophthalmol; 2006 Nov; 142(5):839-48. PubMed ID: 16989765
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutation screening of patients with Leber Congenital Amaurosis or the enhanced S-Cone Syndrome reveals a lack of sequence variations in the NRL gene.
    Acar C; Mears AJ; Yashar BM; Maheshwary AS; Andreasson S; Baldi A; Sieving PA; Iannaccone A; Musarella MA; Jacobson SG; Swaroop A
    Mol Vis; 2003 Jan; 9():14-7. PubMed ID: 12552256
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of the collagen VI assemblies associated with Sorsby's fundus dystrophy.
    Knupp C; Chong NH; Munro PM; Luthert PJ; Squire JM
    J Struct Biol; 2002; 137(1-2):31-40. PubMed ID: 12064931
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel mutations in the carbohydrate sulfotransferase gene (CHST6) in American patients with macular corneal dystrophy.
    Aldave AJ; Yellore VS; Thonar EJ; Udar N; Warren JF; Yoon MK; Cohen EJ; Rapuano CJ; Laibson PR; Margolis TP; Small K
    Am J Ophthalmol; 2004 Mar; 137(3):465-73. PubMed ID: 15013869
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Sorsby fundus dystrophy mutation Timp3(S156C) affects the morphological and biochemical phenotype but not metalloproteinase homeostasis.
    Soboleva G; Geis B; Schrewe H; Weber BH
    J Cell Physiol; 2003 Oct; 197(1):149-56. PubMed ID: 12942551
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A comprehensive survey of mutations in the OPA1 gene in patients with autosomal dominant optic atrophy.
    Thiselton DL; Alexander C; Taanman JW; Brooks S; Rosenberg T; Eiberg H; Andreasson S; Van Regemorter N; Munier FL; Moore AT; Bhattacharya SS; Votruba M
    Invest Ophthalmol Vis Sci; 2002 Jun; 43(6):1715-24. PubMed ID: 12036970
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.